ES357954A1 - Procedimiento para la estabilizacion de acido alfa-lipoico en soluciones farmaceuticas. - Google Patents

Procedimiento para la estabilizacion de acido alfa-lipoico en soluciones farmaceuticas.

Info

Publication number: ES357954A1
Authority: ES; Spain
Prior art keywords: alpha; lipoic acid; translation; machine; legally binding
Prior art date: 1967-09-25
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired

Application number

ES357954A

Other languages

English (en)

Spanish (es)

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

J Pfrimmer und Co GmbH and Co KG

Original Assignee

J Pfrimmer und Co GmbH and Co KG

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1967-09-25

Filing date

1968-09-09

Publication date

1970-04-01

1968-09-09 Application filed by J Pfrimmer und Co GmbH and Co KG filed Critical J Pfrimmer und Co GmbH and Co KG

1970-04-01 Publication of ES357954A1 publication Critical patent/ES357954A1/es

Status Expired legal-status Critical Current

Links

AGBQKNBQESQNJD-UHFFFAOYSA-N lipoic acid Chemical compound OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 title abstract 6
235000019136 lipoic acid Nutrition 0.000 title abstract 3
229960002663 thioctic acid Drugs 0.000 title abstract 3
238000000034 method Methods 0.000 title abstract 2
239000003186 pharmaceutical solution Substances 0.000 title abstract 2
230000006641 stabilisation Effects 0.000 title 1
238000011105 stabilization Methods 0.000 title 1
NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 abstract 2
150000003839 salts Chemical class 0.000 abstract 2
229910000147 aluminium phosphate Inorganic materials 0.000 abstract 1
150000002148 esters Chemical class 0.000 abstract 1
238000001802 infusion Methods 0.000 abstract 1
230000001681 protective effect Effects 0.000 abstract 1
LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 abstract 1
239000000243 solution Substances 0.000 abstract 1
230000000087 stabilizing effect Effects 0.000 abstract 1
239000000126 substance Substances 0.000 abstract 1
229940011671 vitamin b6 Drugs 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
General Health & Medical Sciences (AREA)
Oil, Petroleum & Natural Gas (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Dermatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)

ES357954A 1967-09-25 1968-09-09 Procedimiento para la estabilizacion de acido alfa-lipoico en soluciones farmaceuticas. Expired ES357954A1 (es)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE1617740		1967-09-25

Publications (1)

Publication Number	Publication Date
ES357954A1 true ES357954A1 (es)	1970-04-01

Family

ID=5682288

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ES357954A Expired ES357954A1 (es)	1967-09-25	1968-09-09	Procedimiento para la estabilizacion de acido alfa-lipoico en soluciones farmaceuticas.

Country Status (4)

Country	Link
AT (1)	AT275737B (de)
DE (1)	DE1617740B1 (de)
ES (1)	ES357954A1 (de)
FR (1)	FR1605097A (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2038733T3 (es) *	1987-12-04	1993-08-01	Asta Medica Ag	Procedimiento para preparar una solucion inyectable de la sal de acido tioctico con trometanol y/o aminoacidos basicos.
FR2653997B1 (fr) *	1989-11-09	1995-01-20	Asta Pharma Ag	Medicaments contenant comme sunstances actives des acides carboxyliques soufres, leur preparation et leur utilisation pour lutter contre les retrovirus.
DE102004050353A1 (de) *	2004-10-15	2006-04-20	Basf Ag	Verwendung stabiler Ammoniumsalze der Liponsäure zur Behandlung diabetischer und weiterer Störungen

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE1205972B (de) *	1963-08-20	1965-12-02	Merck Ag E	Verfahren zur Herstellung eines Liponsaeure-derivates

1967
- 1967-09-25 DE DE1967P0043060 patent/DE1617740B1/de not_active Withdrawn
- 1967-12-19 AT AT1145467A patent/AT275737B/de active
1968
- 1968-09-09 ES ES357954A patent/ES357954A1/es not_active Expired
- 1968-09-18 FR FR1605097D patent/FR1605097A/fr not_active Expired

Also Published As

Publication number	Publication date
FR1605097A (en)	1973-01-12
AT275737B (de)	1969-11-10
DE1617740B1 (de)	1971-11-04

Similar Documents

Publication	Publication Date	Title
ES331089A1 (es)	1967-09-16	Procedimiento para la estabilizacion termica de poliamidas.
ES329052A1 (es)	1967-05-01	Metodo de produccion de preparaciones farmaceuticas.
CH553781A (de)	1974-09-13	Verfahren zur herstellung von nikotinsaeure-derivaten von vitamin-b6-verbindungen.
ES286699A1 (es)	1963-11-16	Un método de influir en el crecimiento de las plantas
ES312859A2 (es)	1966-03-01	Un procedimiento para preparar soluciones acuosas y estables de formaldehido.
FR1605097A (en)	1973-01-12	Stable alpha-lipoic acid
ES325416A1 (es)	1967-05-01	Procedimiento para la obtencion de tabletas estables que contienen vitamina c.
YU34531B (en)	1979-09-10	Process for preparing antibacterial compounds of -(cis-1,2-epoxy-propyl)-phosphonic acid
ES334745A1 (es)	1967-10-16	Metodo para el tratamiento de una solucion galvanoplastica acida de estaño.
ES384063A1 (es)	1973-05-01	Procedimiento para la preparacion de soluciones acuosas es-tables de cardenolidas sensibles a la oxidacion.
ES332902A1 (es)	1967-10-01	Procedimiento para la estabilizacion de poliamidas.
ES268449A1 (es)	1961-12-01	Proceso para la preparaciën de un miembro del grupo consistente en una sal de pamoato acido de furaltadona y un hidrato de la misma
ES247110A1 (es)	1959-05-16	Un metodo para la preparaciën de salicilato de colina cristalino, una soluciën acuosa de este o preparaciones terapeuticas del mismo
ES304340A1 (es)	1964-11-01	Procedimiento para la obturaciën de soluciones de albumina humana con bajo contenido en sodio
ES262213A3 (es)	1961-01-01	Un procedimiento para preparar un producto insoluble en agua de vitamina b12
ES324596A1 (es)	1967-02-01	Procedimiento para la preparacion de sales de piridoxina.
ES302294A1 (es)	1965-03-16	Procedimiento para preparar compuestos complejos con yoduro de bismuto de la 2-dehidroemetina.
ES349502A1 (es)	1969-04-01	Procedimiento de preparacion de l-(+)-ascorbato de argini- na.
ES380903A1 (es)	1973-04-01	Un metodo de obtencion de dos sales, biologicamente activas, del acido 2-propilvalerico.
ES238763A1 (es)	1958-07-01	Procedimiento para la obtenciën de un producto multivitaminico acuoso que contenga vitamina b12 en forma estable
ES366888A1 (es)	1971-07-01	Procedimiento para la obtencion de 1-(2-nitrilo-fenoxi) - 2 - hidroxi - 3 - isopropilaminopropano y sus sales.
ES295377A1 (es)	1964-04-16	Procedimiento para la obtencion de ésteres de acido isovalerianico
FR1296497A (fr)	1962-06-15	Procédé perfectionné de préparation de la vitamine b
ES279694A1 (es)	1963-02-01	Procedimiento para la preparaciën de decanoatos de derivados de ciclopentano-polhidrofenantreno
ES288987A1 (es)	1963-12-16	Procedimiento de obtencion de productos farmaceuticos para la terapia salicilica